Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals Statistics

Total Valuation

NSE:BALAXI has a market cap or net worth of INR 1.88 billion. The enterprise value is 2.06 billion.

Market Cap	1.88B
Enterprise Value	2.06B

Important Dates

The next estimated earnings date is Thursday, February 5, 2026.

Earnings Date	Feb 5, 2026
Ex-Dividend Date	n/a

Share Statistics

NSE:BALAXI has 55.21 million shares outstanding. The number of shares has increased by 3.60% in one year.

Current Share Class	55.21M
Shares Outstanding	55.21M
Shares Change (YoY)	+3.60%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.53%
Owned by Institutions (%)	7.73%
Float	12.74M

Valuation Ratios

The trailing PE ratio is 13.03.

PE Ratio	13.03
Forward PE	n/a
PS Ratio	0.68
PB Ratio	0.79
P/TBV Ratio	0.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.42, with an EV/FCF ratio of -5.70.

EV / Earnings	14.20
EV / Sales	0.74
EV / EBITDA	9.42
EV / EBIT	10.31
EV / FCF	-5.70

Financial Position

The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.24.

Current Ratio	3.96
Quick Ratio	2.46
Debt / Equity	0.24
Debt / EBITDA	2.59
Debt / FCF	-1.56
Interest Coverage	4.98

Financial Efficiency

Return on equity (ROE) is 6.39% and return on invested capital (ROIC) is 4.60%.

Return on Equity (ROE)	6.39%
Return on Assets (ROA)	4.09%
Return on Invested Capital (ROIC)	4.60%
Return on Capital Employed (ROCE)	7.62%
Revenue Per Employee	4.61M
Profits Per Employee	241,660
Employee Count	600
Asset Turnover	0.91
Inventory Turnover	1.86

Taxes

In the past 12 months, NSE:BALAXI has paid 35.13 million in taxes.

Income Tax	35.13M
Effective Tax Rate	19.50%

Stock Price Statistics

The stock price has decreased by -58.75% in the last 52 weeks. The beta is 0.59, so NSE:BALAXI's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-58.75%
50-Day Moving Average	40.52
200-Day Moving Average	50.53
Relative Strength Index (RSI)	29.79
Average Volume (20 Days)	117,347

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:BALAXI had revenue of INR 2.76 billion and earned 145.00 million in profits. Earnings per share was 2.62.

Revenue	2.76B
Gross Profit	1.24B
Operating Income	199.71M
Pretax Income	180.12M
Net Income	145.00M
EBITDA	216.73M
EBIT	199.71M
Earnings Per Share (EPS)	2.62

Balance Sheet

The company has 388.49 million in cash and 565.23 million in debt, giving a net cash position of -176.74 million or -3.20 per share.

Cash & Cash Equivalents	388.49M
Total Debt	565.23M
Net Cash	-176.74M
Net Cash Per Share	-3.20
Equity (Book Value)	2.38B
Book Value Per Share	45.56
Working Capital	1.78B

Cash Flow

In the last 12 months, operating cash flow was -34.52 million and capital expenditures -326.92 million, giving a free cash flow of -361.44 million.

Operating Cash Flow	-34.52M
Capital Expenditures	-326.92M
Free Cash Flow	-361.44M
FCF Per Share	-6.55

Margins

Gross margin is 44.94%, with operating and profit margins of 7.22% and 5.24%.

Gross Margin	44.94%
Operating Margin	7.22%
Pretax Margin	6.51%
Profit Margin	5.24%
EBITDA Margin	7.84%
EBIT Margin	7.22%
FCF Margin	n/a

Dividends & Yields

NSE:BALAXI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.60%
Shareholder Yield	-3.60%
Earnings Yield	7.70%
FCF Yield	-19.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 30, 2024. It was a forward split with a ratio of 5.

Last Split Date	May 30, 2024
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	3